ecancermedicalscience

Review

Complications from carcinoid syndrome: review of the current evidence

8 Aug 2016
José Mauricio Mota, Luana Guimarães Sousa, Rachel P Riechelmann

Patients with well-differentiated neuroendocrine tumours may develop carcinoid syndrome (CS), which is characterised by flushing, abdominal cramps, diarrhoea, and bronchospasms. In this scenario, long-term secretion of vasoactive substances—serotonin, tachynins, and others, may induce fibrogenic responses in local or distant tissues, leading to complications such as carcinoid heart disease (CHD), mesenteric and/or retroperitoneal fibrosis. Rare cases of lung/pleural fibrosis and scleroderma have also been described. Despite it not being well described yet, current evidence suggests the pathogenesis of such fibrogenic complications relies on signalling through 5-HT2B and TGF-β1. Medical management is still very limited and lacks prospective and randomised studies for definitive recommendations. Surgical procedures remain the best definitive treatment option for CHD and abdominal fibrosis. Recently, cognitive impairment has also been described as a potential consequence of CS. This review critically discusses the literature concerning the epidemiology, pathogenesis, clinical features, diagnosis, and treatment options for CS-related long-term complications.

Article metrics: 9449 views
1343
8106

Related Articles

Lekha Madhavan Nair, KM Jagathnath Krishna, Aswin Kumar, Susan Mathews, John Joseph, Francis Vadakkumparambil James
Hugo Tanaka, Deise Uema, Juliana FM Rego, Rui F Weschenfelder, Nathalia D’Agustini, Duilio R Rocha Filho, Juan M O'Connor, Romina Luca, Jose Eduardo R Nuñez, Milton José de Barros e Silva, Rachel P Riechelmann
Paola Zagami, Eleni Kandaraki, Giuseppe Renne, Franco Grimaldi, Francesca Spada, Alice Laffi, Nicola Fazio
Vijay M Patil, Gunjesh Kumar Singh, Vanita Noronha, Amit Joshi, Nandini Menon, Sarbani Ghosh Lashkar, Vijayalakshmi Mathrudev, Kavita Nawale Satam, Sadaf Abdulazeez Mukadam, Kumar Prabhash